Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer

1993 ◽  
Vol 36 (4) ◽  
pp. 267-273 ◽  
Author(s):  
Gary E. Goodman ◽  
Ingegerd Hellstrom ◽  
Dale E. Yelton ◽  
James L. Murray ◽  
Sarah O'Hara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Small Cell ◽  
Mouse Monoclonal Antibody ◽  
Small Cell Lung

scholarly journals p53 gene therapy for non-small cell lung cancer: a preliminary report of phase I trial

2000 ◽  
Vol 82 ◽  
pp. 36
Author(s):  
Toshivoshi Fujiwara ◽  
Masafumi Kataoka ◽  
Atsushi Nakamura ◽  
Noriaki Tanaka
Keyword(s):  
Lung Cancer ◽  
Gene Therapy ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Preliminary Report ◽  
Phase I Trial ◽  
P53 Gene ◽  
Small Cell ◽  
Small Cell Lung

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2013 ◽  
Vol 79 (3) ◽  
pp. 270-275 ◽  
Author(s):  
Se Hyun Kim ◽  
Hyo Sup Shim ◽  
Jaeho Cho ◽  
Jae Heon Jeong ◽  
Sun Mi Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Trial ◽  
Small Cell ◽  
Small Cell Lung

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

2007 ◽  
Vol 56 (10) ◽  
pp. 1637-1644 ◽  
Author(s):  
Martin Sebastian ◽  
Bernward Passlick ◽  
Hilke Friccius-Quecke ◽  
Michael Jäger ◽  
Horst Lindhofer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document